The Nasdaq Stock Market ended the session with Moderna jumping 6.48% to $169.86 on Tuesday while the Nasdaq Stock Market jumped 0.45% to $12,576.50.

Moderna today’s close was $169.86, 5.09% under its 52-week high of $178.50.

News about Moderna today

Moderna says Swiss government has increased its Covid vaccine order to 7.5 million doses from 4.5 million. According to today’s article on MarketWatch, “Moderna said it’s on track to start delivering the vaccine as soon as it gets the nod from Swiss regulators. “Moderna could ship its COVID-19 vaccine as soon as December if regulatory approval is granted this month,’ the company said in a statement.”

Moderna’s Sales

Moderna’s sales growth is 1428.1% for the ongoing quarter and 13065.3% for the next. The company’s growth estimates for the current quarter is a negative 48.6% and positive 565.7% for the next.

Moderna’s Revenue

Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.

Moderna’s Stock Top and Bottom Yearly Value

Moderna’s stock is valued at $169.86 at 16:29 EST, under its 52-week high of $178.50 and way above its 52-week low of $17.68.

Moderna’s Moving Average

Moderna’s value is way above its 50-day moving average of $93.51 and way higher than its 200-day moving average of $74.48.

LEAVE A REPLY

Please enter your comment!
Please enter your name here